Three stories worth your time today. Pentagon money, Nvidia's China problem, and a real medical win from Mayo Clinic. Let's get into it.
Pentagon Hands Out AI Contracts and Anthropic Walks
On May 1, the Pentagon awarded classified-network AI contracts to AWS, Google, Microsoft, Nvidia, OpenAI, SpaceX, and Reflection AI. Anthropic was not on the list.
The why is the part that matters. Anthropic refused to let Claude be used for "all lawful" purposes. They flagged the language as too broad, saying it could open the door to domestic mass surveillance or autonomous weapons.
Why it matters: there's a real split now between AI labs willing to take any defense dollar and labs that draw a line in the sand. The Pentagon wrote a blank check, and one company said no thanks.
My take: I respect Anthropic for this. You can't build a "safe AI" brand and then hand the keys to whatever a contracting officer feels like doing on a Tuesday. The dollars are big. The trust they keep is bigger. Other labs ought to pay attention because customers in regulated industries are watching too.
Nvidia's China AI Share Just Hit Zero
Jensen Huang said this week that Nvidia's market share for AI accelerators in China is now zero. Huawei, Cambricon, and other domestic chip outfits are filling the gap.
Huang argued the U.S. export controls have "already largely backfired." Hard to disagree when your share goes from dominant to nothing in a couple of years.
Why it matters: export controls were supposed to slow China down. Instead they pushed China to build its own stack. Now there are two separate AI hardware worlds, and the American one no longer ships into the bigger market.
My take: this was always the risk with broad export controls. You don't strangle a country with this much capital and this many engineers. You just give them a five-year head start on import substitution. The U.S. lost a customer and gained a competitor in the same trade. That's a bad day on the chess board.
Mayo Clinic Says AI Can Spot Pancreatic Cancer Years Early
Mayo Clinic researchers showed an AI model that flags pancreatic cancer years before clinical diagnosis. Pancreatic is one of the worst because by the time you feel something, it's usually late.
Why it matters: this is the kind of work that justifies all the noise around AI in medicine. Not chatbots that summarize charts. Not slick demos. Pattern recognition on imaging and labs that actually saves lives.
My take: more of this please. Less PR theater about agents that can book your dentist appointment, more boring research that catches a cancer two years before a human radiologist would. Mayo is doing it right by publishing real results instead of dropping a press release and hiding the data.
Putting It Together
One day, three signals. AI vendors are getting sorted into camps based on who they will sell to. Hardware policy is shifting under everybody's feet. And the actual humans-helping-humans use cases are quietly winning while the rest of the field argues on Twitter.
Worth paying attention to all of it.